Financial Statements

Anthera Pharmaceuticals Inc.

Anthera Pharmaceuticals Inc. (ANTH)


Balance Sheet Statement

Download ANTH income statement Download ANTH income statement
Year 20132014201520162017
Cash and cash equivalents 26.003.0047.0021.002.00
Short-term investments -----
Cash and short-term investments -----
Receivables -----
Inventories -----
Property, Plant & Equipment Net 1.00--1.00-
Goodwill and Intangible Assets -----
Long-term investments -----
Tax assets -----
Total non-current assets 15.00---4.00
Total current assets 11.00--1.00-
Total assets 37.003.0048.0023.004.00
Short-term debt 3.00----
Total current liabilities
Long-term debt 15.00----
Total debt 15.00----
Deferred revenue -----
Tax Liabilities -----
Deposit Liabilities -----
Total non-current liabilities 15.00---4.00
Total liabilities
Other comprehensive income -----
Retained earnings (deficit) -287.00-317.00-352.00-408.00-434.00
Total stockholders equity -----
Investments -----
Net Debt -8.00-3.00-47.00-21.00-2.00
Other Assets 10.00----
Other Liabilities -

Anthera Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Anthera Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.